APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer's disease pathology

被引:9
|
作者
Chemparathy, Augustine [1 ]
Guen, Yann Le [1 ,2 ]
Chen, Sunny [3 ]
Lee, Eun-Gyung [3 ]
Leong, Lesley
Gorzynski, John E. [4 ]
Jensen, Tanner D. [4 ]
Ferrasse, Alexis [4 ]
Xu, Guangxue [4 ]
Xiang, Hong [4 ]
Belloy, Michael E. [1 ]
Kasireddy, Nandita [1 ,7 ]
Pena-Tauber, Andres [1 ]
Williams, Kennedy [1 ]
Stewart, Ilaria [1 ]
Talozzi, Lia [1 ]
Wingo, Thomas S. [5 ,6 ]
Lah, James J.
Jayadev, Suman [8 ]
Hales, Chadwick M. [7 ,8 ]
Peskind, Elaine [9 ,10 ]
Child, Daniel D. [11 ]
Roeber, Sigrun [12 ]
Keene, C. Dirk [11 ]
Cong, Le [4 ]
Ashley, Euan A. [4 ,13 ,14 ]
Yu, Chang -En [3 ,15 ]
Greicius, Michael D. [1 ]
机构
[1] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Med, Quantitat Sci Unit, Stanford, CA USA
[3] VA Puget Sound Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Seattle, WA USA
[4] Stanford Univ, Sch Med, Dept Genet, Stanford, CA USA
[5] Emory Univ, Sch Med, Atlanta, GA USA
[6] Emory Univ, Sch Med, Goizueta Alzheimers Dis Ctr, Atlanta, GA USA
[7] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA USA
[8] Univ Washington, Dept Neurol, Seattle, WA USA
[9] Vet Affairs Puget Sound Hlth Care Syst, Vet Affairs Northwest Network, Mental Illness Res Educ & Clin Ctr, Seattle, WA USA
[10] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA USA
[11] Univ Washington, Dept Lab Med & Pathol, Sch Med, Seattle, WA USA
[12] Ludwig Maximilians Univ Munchen, Fac Med, Ctr Neuropathol & Prion Res, Munich, Germany
[13] Stanford Univ, Ctr Inherited Cardiovasc Dis, Stanford, CA USA
[14] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA USA
[15] Univ Washington, Dept Med, Seattle, WA USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
APOLIPOPROTEIN-E; NEUROCOGNITIVE FUNCTION; AGE; MODEL;
D O I
10.1016/j.neuron.2024.01.008
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The e 4 allele of apolipoprotein E ( APOE ) is the strongest genetic risk factor for sporadic Alzheimer's disease (AD). Knockdown of e 4 may provide a therapeutic strategy for AD, but the effect of APOE loss of function (LoF) on AD pathogenesis is unknown. We searched for APOE LoF variants in a large cohort of controls and patients with AD and identified seven heterozygote carriers of APOE LoF variants. Five carriers were controls (aged 71-90 years), one carrier was affected by progressive supranuclear palsy, and one carrier was affected by AD with an unremarkable age at onset of 75 years. Two APOE e 3/ e 4 controls carried a stop -gain affecting e 4: one was cognitively normal at 90 years and had no neuritic plaques at autopsy; the other was cognitively healthy at 79 years, and lumbar puncture at 76 years showed normal levels of amyloid. These results suggest that e 4 drives AD risk through the gain of abnormal function and support e 4 knockdown as a viable therapeutic option.
引用
收藏
页码:1110 / 1116.e5
页数:13
相关论文
共 50 条
  • [1] Missense and loss-of-function variants at GWAS loci in familial Alzheimer's disease
    Gunasekaran, Tamil Iniyan
    Reyes-Dumeyer, Dolly
    Faber, Kelley M.
    Goate, Alison
    Boeve, Brad
    Cruchaga, Carlos
    Pericak-Vance, Margaret
    Haines, Jonathan L.
    Rosenberg, Roger
    Tsuang, Debby
    Mejia, Diones Rivera
    Medrano, Martin
    Lantigua, Rafael A.
    Sweet, Robert A.
    Bennett, David A.
    Wilson, Robert S.
    Alba, Camille
    Dalgard, Clifton
    Foroud, Tatiana
    Vardarajan, Badri N.
    Mayeux, Richard
    ALZHEIMERS & DEMENTIA, 2024, 20 (11) : 7580 - 7594
  • [2] Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
    Steinberg, Stacy
    Stefansson, Hreinn
    Jonsson, Thorlakur
    Johannsdottir, Hrefna
    Ingason, Andres
    Helgason, Hannes
    Sulem, Patrick
    Magnusson, Olafur Th
    Gudjonsson, Sigurjon A.
    Unnsteinsdottir, Unnur
    Kong, Augustine
    Helisalmi, Seppo
    Soininen, Hilkka
    Lah, James J.
    Aarsland, Dag
    Fladby, Tormod
    Ulstein, Ingun D.
    Djurovic, Srdjan
    Sando, Sigrid B.
    White, Linda R.
    Knudsen, Gun-Peggy
    Westlye, Lars T.
    Selbaek, Geir
    Giegling, Ina
    Hampel, Harald
    Hiltunen, Mikko
    Levey, Allan I.
    Andreassen, Ole A.
    Rujescu, Dan
    Jonsson, Palmi V.
    Bjornsson, Sigurbjorn
    Snaedal, Jon
    Stefansson, Kari
    NATURE GENETICS, 2015, 47 (05) : 445 - U24
  • [3] Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
    Stacy Steinberg
    Hreinn Stefansson
    Thorlakur Jonsson
    Hrefna Johannsdottir
    Andres Ingason
    Hannes Helgason
    Patrick Sulem
    Olafur Th Magnusson
    Sigurjon A Gudjonsson
    Unnur Unnsteinsdottir
    Augustine Kong
    Seppo Helisalmi
    Hilkka Soininen
    James J Lah
    Dag Aarsland
    Tormod Fladby
    Ingun D Ulstein
    Srdjan Djurovic
    Sigrid B Sando
    Linda R White
    Gun-Peggy Knudsen
    Lars T Westlye
    Geir Selbæk
    Ina Giegling
    Harald Hampel
    Mikko Hiltunen
    Allan I Levey
    Ole A Andreassen
    Dan Rujescu
    Palmi V Jonsson
    Sigurbjorn Bjornsson
    Jon Snaedal
    Kari Stefansson
    Nature Genetics, 2015, 47 : 445 - 447
  • [4] APOE2 is associated with longevity independent of Alzheimer's disease
    Shinohara, Mitsuru
    Kanekiyo, Takahisa
    Tachibana, Masaya
    Kurti, Aishe
    Shinohara, Motoko
    Fu, Yuan
    Zhao, Jing
    Han, Xianlin
    Sullivan, Patrick M.
    Rebeck, G. William
    Fryer, John D.
    Heckman, Michael G.
    Bu, Guojun
    ELIFE, 2020, 9 : 1 - 16
  • [5] Loss-of-Function PCSK9 Mutations Are Not Associated With Alzheimer Disease
    Paquette, Martine
    Saavedra, Yascara Grisel Luna
    Poirier, Judes
    Theroux, Louise
    Dea, Doris
    Baass, Alexis
    Dufour, Robert
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2018, 31 (02) : 90 - 96
  • [6] The Effect of Alzheimer's Disease-Associated Genetic Variants on Longevity
    Tesi, Niccolo
    Hulsman, Marc
    van der Lee, Sven J.
    Jansen, Iris E.
    Stringa, Najada
    van Schoor, Natasja M.
    Scheltens, Philip
    van der Flier, Wiesje M.
    Huisman, Martijn
    Reinders, Marcel J. T.
    Holstege, Henne
    FRONTIERS IN GENETICS, 2021, 12
  • [7] APOE loss of function: A genetic shield against Alzheimer's disease
    Tate, Mason D.
    Karahan, Hande
    Kim, Jungsu
    NEURON, 2024, 112 (07) : 1033 - 1035
  • [8] Carriers of Heterozygous Loss-of-Function ACE Mutations Are at Risk for Alzheimer's Disease
    Danilov, Sergei M.
    Adzhubei, Ivan A.
    Kozuch, Alexander J.
    Petukhov, Pavel A.
    Popova, Isolda A.
    Choudhury, Ananyo
    Sengupta, Dhriti
    Dudek, Steven M.
    BIOMEDICINES, 2024, 12 (01)
  • [9] The presenilin hypothesis of Alzheimer's disease: Evidence for a loss-of-function pathogenic mechanism
    Shen, Jie
    Kelleher, Raymond J., III
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (02) : 403 - 409
  • [10] Filaggrin Loss-of-Function Variants are Associated with Atopic Comorbidity in Pediatric Inflammatory Bowel Disease
    Van Limbergen, J.
    Russell, R. K.
    Nimmo, E. R.
    Zhao, Y.
    Liao, H.
    Drummond, H. E.
    Davies, G.
    Gillett, P. M.
    McGrogan, P.
    Bisset, W. M.
    Mahdi, G.
    Wilson, D. C.
    Brown, S. J.
    McLean, W. H. I.
    Satsangi, J.
    INFLAMMATORY BOWEL DISEASES, 2009, 15 (10) : 1492 - 1498